Dafna Capital Management LLC Biomea Fusion, Inc. Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$9.51 - $13.61 $972,968 - $1.39 Million
-102,310 Reduced 74.71%
34,625 $339,000
Q2 2022

Aug 15, 2022
SELL
$3.0 - $12.03 $740,964 - $2.97 Million
-246,988 Reduced 64.33%
136,935 $1.64 Million
Q1 2022

May 16, 2022
BUY
$4.39 - $9.03 $307,300 - $632,100
70,000 Added 22.3%
383,923 $1.71 Million
Q4 2021

Feb 14, 2022
BUY
$7.22 - $12.72 $2.27 Million - $3.99 Million
313,923 New
313,923 $2.34 Million

Others Institutions Holding BMEA

# of Institutions
105
Shares Held
17.9M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $119M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email